Literature DB >> 9723323

Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year.

G F Cooney1, V Jeevanandam, S Choudhury, G Feutren, E A Mueller, H J Eisen.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9723323     DOI： 10.1016/s0041-1345(98)00472-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

1.  Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates.

Authors:  C Balram; A Sharma; C Sivathasan; Edmund J D Lee
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

Review 2.  Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.

Authors:  P Belitsky; S Dunn; A Johnston; G Levy
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

3.  Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients.

Authors:  Franck Saint-Marcoux; Pierre Marquet; Evelyne Jacqz-Aigrain; Nicole Bernard; Philippe Thiry; Yann Le Meur; Annick Rousseau
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 4.  Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.

Authors:  C J Dunn; A J Wagstaff; C M Perry; G L Plosker; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 5.  Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.

Authors:  Atholl Johnston; Philip Belitsky; Ulrich Frei; John Horvath; Peter Hoyer; J Harold Helderman; Michael Oellerich; Stephen Pollard; Hany Riad; Paolo Rigotti; Paul Keown; Björn Nashan
Journal:  Eur J Clin Pharmacol       Date:  2004-06-17       Impact factor: 2.953

6.  Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.

Authors:  C Monchaud; A Rousseau; F Leger; O J David; J Debord; T Dantoine; P Marquet
Journal:  Eur J Clin Pharmacol       Date:  2003-03-06       Impact factor: 2.953

7.  In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate.

Authors:  You-Meei Lin; Jui-Yu Wu; Ying-Chen Chen; Yu-Der Su; Wen-Tin Ke; Hsiu-O Ho; Ming-Thau Sheu
Journal:  Int J Nanomedicine       Date:  2011-10-19

8.  Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange.

Authors:  A K Singh; S S Narsipur
Journal:  J Transplant       Date:  2011-11-17

9.  Development and characterization of dilutable self-microemulsifying premicroemulsion systems (SMEPMS) as templates for preparation of nanosized particulates.

Authors:  Shen-Fu Lin; Ying-Chen Chen; Hsiu-O Ho; Wei-Yu Huang; Ming-Thau Sheu; Der-Zen Liu
Journal:  Int J Nanomedicine       Date:  2013-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.